These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 17522343

  • 1. Antigen-specific suppression of experimental autoimmune encephalomyelitis by a novel bifunctional peptide inhibitor.
    Kobayashi N, Kobayashi H, Gu L, Malefyt T, Siahaan TJ.
    J Pharmacol Exp Ther; 2007 Aug; 322(2):879-86. PubMed ID: 17522343
    [Abstract] [Full Text] [Related]

  • 2. Antigen-specific suppression of experimental autoimmune encephalomyelitis by a novel bifunctional peptide inhibitor: structure optimization and pharmacokinetics.
    Ridwan R, Kiptoo P, Kobayashi N, Weir S, Hughes M, Williams T, Soegianto R, Siahaan TJ.
    J Pharmacol Exp Ther; 2010 Mar; 332(3):1136-45. PubMed ID: 20026673
    [Abstract] [Full Text] [Related]

  • 3. Prophylactic and therapeutic suppression of experimental autoimmune encephalomyelitis by a novel bifunctional peptide inhibitor.
    Kobayashi N, Kiptoo P, Kobayashi H, Ridwan R, Brocke S, Siahaan TJ.
    Clin Immunol; 2008 Oct; 129(1):69-79. PubMed ID: 18676182
    [Abstract] [Full Text] [Related]

  • 4. Controlling immune response and demyelination using highly potent bifunctional peptide inhibitors in the suppression of experimental autoimmune encephalomyelitis.
    Kiptoo P, Büyüktimkin B, Badawi AH, Stewart J, Ridwan R, Siahaan TJ.
    Clin Exp Immunol; 2013 Apr; 172(1):23-36. PubMed ID: 23480182
    [Abstract] [Full Text] [Related]

  • 5. Suppression of MOG- and PLP-induced experimental autoimmune encephalomyelitis using a novel multivalent bifunctional peptide inhibitor.
    Badawi AH, Siahaan TJ.
    J Neuroimmunol; 2013 Oct 15; 263(1-2):20-7. PubMed ID: 23911075
    [Abstract] [Full Text] [Related]

  • 6. Immune response to controlled release of immunomodulating peptides in a murine experimental autoimmune encephalomyelitis (EAE) model.
    Zhao H, Kiptoo P, Williams TD, Siahaan TJ, Topp EM.
    J Control Release; 2010 Jan 25; 141(2):145-52. PubMed ID: 19748537
    [Abstract] [Full Text] [Related]

  • 7. Characterization of proteolipid protein-peptide-specific CD(4)(+) T cell of experimental allergic encephalomyelitis in Biozzi AB/H mice.
    Peng Y, Liu CP.
    Chin Med J (Engl); 2002 Apr 25; 115(4):521-4. PubMed ID: 12133288
    [Abstract] [Full Text] [Related]

  • 8. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis.
    Whitham RH, Bourdette DN, Hashim GA, Herndon RM, Ilg RC, Vandenbark AA, Offner H.
    J Immunol; 1991 Jan 01; 146(1):101-7. PubMed ID: 1701788
    [Abstract] [Full Text] [Related]

  • 9. Monomeric recombinant TCR ligand reduces relapse rate and severity of experimental autoimmune encephalomyelitis in SJL/J mice through cytokine switch.
    Huan J, Subramanian S, Jones R, Rich C, Link J, Mooney J, Bourdette DN, Vandenbark AA, Burrows GG, Offner H.
    J Immunol; 2004 Apr 01; 172(7):4556-66. PubMed ID: 15034073
    [Abstract] [Full Text] [Related]

  • 10. Location of a new encephalitogenic epitope (residues 43 to 64) in proteolipid protein that induces relapsing experimental autoimmune encephalomyelitis in PL/J and (SJL x PL)F1 mice.
    Whitham RH, Jones RE, Hashim GA, Hoy CM, Wang RY, Vandenbark AA, Offner H.
    J Immunol; 1991 Dec 01; 147(11):3803-8. PubMed ID: 1719089
    [Abstract] [Full Text] [Related]

  • 11. Eluding anaphylaxis allows peptide-specific prevention of the relapsing stage of experimental autoimmune encephalomyelitis.
    Wegmann KW, Archie Bouwer HG, Whitham RH, Hinrichs DJ.
    J Neuroimmunol; 2014 Sep 15; 274(1-2):46-52. PubMed ID: 24997489
    [Abstract] [Full Text] [Related]

  • 12. Treatment of relapsing experimental autoimmune encephalomyelitis with T cell receptor peptides.
    Whitham RH, Kotzin BL, Buenafe AC, Weinberg AD, Jones RE, Hashim GA, Hoy CM, Vandenbark AA, Offner H.
    J Neurosci Res; 1993 Jun 01; 35(2):115-28. PubMed ID: 7686583
    [Abstract] [Full Text] [Related]

  • 13. Immunogenic and encephalitogenic epitope clusters of myelin proteolipid protein.
    Greer JM, Sobel RA, Sette A, Southwood S, Lees MB, Kuchroo VK.
    J Immunol; 1996 Jan 01; 156(1):371-9. PubMed ID: 8598487
    [Abstract] [Full Text] [Related]

  • 14. Immune responses of linear and cyclic PLP139-151 mutant peptides in SJL/J mice: peptides in their free state versus mannan conjugation.
    Katsara M, Deraos S, Tselios TV, Pietersz G, Matsoukas J, Apostolopoulos V.
    Immunotherapy; 2014 Jan 01; 6(6):709-24. PubMed ID: 25186603
    [Abstract] [Full Text] [Related]

  • 15. Soluble mannosylated myelin peptide inhibits the encephalitogenicity of autoreactive T cells during experimental autoimmune encephalomyelitis.
    Kel J, Oldenampsen J, Luca M, Drijfhout JW, Koning F, Nagelkerken L.
    Am J Pathol; 2007 Jan 01; 170(1):272-80. PubMed ID: 17200200
    [Abstract] [Full Text] [Related]

  • 16. Sequence 104-117 of myelin proteolipid protein is a cryptic encephalitogenic T cell determinant for SJL/J mice.
    Tuohy VK, Thomas DM.
    J Neuroimmunol; 1995 Feb 01; 56(2):161-70. PubMed ID: 7532182
    [Abstract] [Full Text] [Related]

  • 17. IL-4, IL-10, IL-13, and TGF-beta from an altered peptide ligand-specific Th2 cell clone down-regulate adoptive transfer of experimental autoimmune encephalomyelitis.
    Young DA, Lowe LD, Booth SS, Whitters MJ, Nicholson L, Kuchroo VK, Collins M.
    J Immunol; 2000 Apr 01; 164(7):3563-72. PubMed ID: 10725711
    [Abstract] [Full Text] [Related]

  • 18. Relapsing and remitting experimental allergic encephalomyelitis: a focused response to the encephalitogenic peptide rather than epitope spread.
    Takács K, Chandler P, Altmann DM.
    Eur J Immunol; 1997 Nov 01; 27(11):2927-34. PubMed ID: 9394820
    [Abstract] [Full Text] [Related]

  • 19. Induction of experimental allergic encephalomyelitis by myelin proteolipid-protein-specific T cell clones and synthetic peptides.
    Kuchroo VK, Sobel RA, Yamamura T, Greenfield E, Dorf ME, Lees MB.
    Pathobiology; 1991 Nov 01; 59(5):305-12. PubMed ID: 1716908
    [Abstract] [Full Text] [Related]

  • 20. Male SJL mice do not relapse after induction of EAE with PLP 139-151.
    Bebo BF, Vandenbark AA, Offner H.
    J Neurosci Res; 1996 Sep 15; 45(6):680-9. PubMed ID: 8892079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.